Compare PRTA & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRTA | VREX |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.8M | 483.7M |
| IPO Year | N/A | N/A |
| Metric | PRTA | VREX |
|---|---|---|
| Price | $9.12 | $13.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $18.86 | $16.67 |
| AVG Volume (30 Days) | ★ 729.9K | 290.9K |
| Earning Date | 02-19-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $11,786,000.00 | ★ $844,600,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | $819.08 | $4.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.14 |
| 52 Week Low | $4.32 | $6.76 |
| 52 Week High | $16.67 | $15.46 |
| Indicator | PRTA | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 40.87 | 74.59 |
| Support Level | $8.95 | $11.48 |
| Resistance Level | $9.47 | $12.14 |
| Average True Range (ATR) | 0.37 | 0.45 |
| MACD | -0.03 | 0.15 |
| Stochastic Oscillator | 22.61 | 95.15 |
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.